Sciele Home Sciele Products Page Product Development Pipeline Sciele Business Development Sciele Investor Relations Sciele Career Page Sciele Contact Information
 

Clonibid/Clonicel

Press Releases:

Sciele Pharma Announces That Addrenex Has Completed Enrollment of Pivotal Phase III Trial for CLONICEL® for ADHD

Sciele Pharma Announces FDA Acceptance of NDA for Addrenex Pharmaceuticals' CloniBID to Treat Hypertension

Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for CLONICEL® for ADHD

Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL®

Presentations:

 

Back to Pipeline

Adobe® Reader® is required to view our Prescribing Information documents;
click here to download this free program.

This web site and its contents are intended for use only by residents of the United States. Products discussed may have different labeling, regulatory requirements, and/or medical practices in other countries that may require reference to different or additional information.